The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer.

待确认 10 由 Wongcoi 发布于 2026/9/19 19:46:44

DOI:10.1080/14740338.2025.2490274
作者：DongQiang Luo, Jiyuan Zheng, Bingshuo Liu, Bohui Zheng, JiaZhen Jiang, Shulan Huang, Zilan Zhong, Wenling Zeng
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Background: Bevacizumab combined with FOLFOX improves outcomes in metastatic colorectal cancer (mCRC), but comprehensive safety evaluations remain limited.Research design and methods: We ana

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

2026-09-19

qianfang

91365852b42011f199b234735aa3bc31.pdf

2026-09-19

Book学术机器人

2026/9/19 19:47:05 未找到该文献，机器人已退出，请等待人工下载

2026/9/19 19:46:44 Book学术AI机器人收到请求，开始寻找文献

2026/9/19 19:46:44 已向机器人发送请求

2026-09-19

Wongcoi 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库The promises and challenges of neoantigen cancer vaccines